DELTF yields 2.21% · JNJ yields 2.14%● Live data
📍 DELTF pulled ahead of the other in Year 1
Combined, DELTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DELTF + JNJ for your $10,000?
Delta Galil Industries Ltd. engages in the design, development, production, marketing, and sale of apparel products worldwide. It operates through five segments: Delta USA, Global Upper Market, Delta European Brands, Delta Premium Brands, and Delta Israel. The company offers intimate apparel for women, including panties, brassieres, nightwear, and seamless garments, such as shapewear and activewear; undergarments for men; socks for men, women, and children; children's wear; denim clothing item; and women's outerwear such as shirts, dresses, jackets, pants, tops, swimwear, and other products. It also provides leisure wear, active wear, and sportswear. The company offers its products primarily under the 7 For All Mankind, Schiesser, Eminence, Athena, Secret by Athena, Delta Israel, Fix, P.J. Salvage, Splendid, Liabel, Karen Neuburger, and Nearly Nude brands. It also provides its products under the brand names licensed to the company and private labels. The company is also involved in the development, design, marketing, distribution, and sale of branded products in the jeans and over wear clothing and ancillary products. The company sells its products through its own retail shops and outlets, as well as through an online store. Delta Galil Industries Ltd. was incorporated in 1975 and is headquartered in Caesarea, Israel.
Full DELTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.